Endocrinology

Episodes 1-14 of 14

• 

  CME/CE Meeting

  The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care 

  November 16, 2024

  1.50 credits Learn more

• 

  RestartResume

  The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care 

  RestartResume

  The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care 

  CME/CE Live Broadcast

  The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care 

  November 16, 2024

  08:00 PM - 09:30 PM PST

  1.50 credits Learn more

• 

  RestartResume

  More Screening Recommendations? These Could Save Your Patient's Life

  RestartResume

  More Screening Recommendations? These Could Save Your Patient's Life

  MinuteCE®

  More Screening Recommendations? These Could Save Your Patient's Life

  1.00 program credit

  • 

    

    Tessa Janovsky, PA-C

  1.00 program credit

• 

  MinuteCE®

  Endocrinologists and PCPs: The Frontline Defense Against Cirrhosis in Patients with Type 2 Diabetes 

  1.00 credit 9 episodes

  • 

    

    Jeff McIntyre

  • 

    

    Naim Alkhouri, MD, FAASLD, DABOM

  • 

    

    Robert H. Eckel, MD, FAHA, FACC, FNLA

  • 

    

    Tessa Janovsky, PA-C

  1.00 credit 9 episodes

• 

  RestartResume

  I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis

  RestartResume

  I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis

  MinuteCE®

  I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis

  1.00 program credit

  • 

    

    Naim Alkhouri, MD, FAASLD, DABOM

  • 

    

    Tessa Janovsky, PA-C

  1.00 program credit

• 

  RestartResume

  You Want Me to Perform a Liver Stiffness Test in My Clinic, Did I Hear That Right?

  RestartResume

  You Want Me to Perform a Liver Stiffness Test in My Clinic, Did I Hear That Right?

  MinuteCE®

  You Want Me to Perform a Liver Stiffness Test in My Clinic, Did I Hear That Right?

  1.00 program credit

  • 

    

    Naim Alkhouri, MD, FAASLD, DABOM

  1.00 program credit

• 

  RestartResume

  Treating Patients With T2D and MASLD: Is the Tide Changing?

  RestartResume

  Treating Patients With T2D and MASLD: Is the Tide Changing?

  MinuteCE®

  Treating Patients With T2D and MASLD: Is the Tide Changing?

  1.00 program credit

  • 

    

    Naim Alkhouri, MD, FAASLD, DABOM

  1.00 program credit

• 

  RestartResume

  It All Starts With a Patient

  RestartResume

  It All Starts With a Patient

  MinuteCE®

  It All Starts With a Patient

  1.00 program credit

  • 

    

    Jeff McIntyre

  1.00 program credit

• 

  RestartResume

  Noninvasive Tests for Clinically Significant Fibrosis: That's The Hepatologist's Job, Right?

  RestartResume

  Noninvasive Tests for Clinically Significant Fibrosis: That's The Hepatologist's Job, Right?

  MinuteCE®

  Noninvasive Tests for Clinically Significant Fibrosis: That's The Hepatologist's Job, Right?

  1.00 program credit

  • 

    

    Naim Alkhouri, MD, FAASLD, DABOM

  1.00 program credit

• 

  RestartResume

  My Patient's At 'Low Risk' for Clinically Significant Fibrosis: What Should I Do Now?

  RestartResume

  My Patient's At 'Low Risk' for Clinically Significant Fibrosis: What Should I Do Now?

  MinuteCE®

  My Patient's At 'Low Risk' for Clinically Significant Fibrosis: What Should I Do Now?

  1.00 program credit

  • 

    

    Robert H. Eckel, MD, FAHA, FACC, FNLA

  1.00 program credit

• 

  RestartResume

  MASLD in My Clinic: Hiding in Plain Sight?

  RestartResume

  MASLD in My Clinic: Hiding in Plain Sight?

  MinuteCE®

  MASLD in My Clinic: Hiding in Plain Sight?

  1.00 program credit

  • 

    

    Robert H. Eckel, MD, FAHA, FACC, FNLA

  1.00 program credit

• 

  RestartResume

  M3: Managing the Cardiometabolic Risk in MASH

  RestartResume

  M3: Managing the Cardiometabolic Risk in MASH

  MinuteCE®

  M3: Managing the Cardiometabolic Risk in MASH

  1.00 program credit

  • 

    

    Robert H. Eckel, MD, FAHA, FACC, FNLA

  • 

    

    Naim Alkhouri, MD, FAASLD, DABOM

  1.00 program credit

• 

  RestartResume

  Overcoming Clinical Inertia in Hyperkalemia Management

  RestartResume

  Overcoming Clinical Inertia in Hyperkalemia Management

  CME/CE

  Overcoming Clinical Inertia in Hyperkalemia Management

  0.25 credits

  • 

    

    Peter Rossing, MD, DMSc

  • 

    

    Michael Böhm, MD, FESC

  • 

    

    Luca De Nicola, MD, PhD

  0.25 credits

• 

  RestartResume

  Hyperkalemia in CKD and HFrEF…What Am I Missing? 

  RestartResume

  Hyperkalemia in CKD and HFrEF…What Am I Missing? 

  CME/CE

  Hyperkalemia in CKD and HFrEF…What Am I Missing? 

  0.25 credits

  • 

    

    George L. Bakris, MD, FAHA, FASN

  • 

    

    David Bushinsky, MD

  • 

    

    Lars Lund, MD

  0.25 credits